Not applicableStudy completedNCT00563355
What this trial is testing
Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients
Who this might be right for
Chronic DiseaseKidney DiseasesCardiovascular Diseases
Hospital Authority, Hong Kong 66